Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
Approximately 17% of all patients with stroke are classified as having ESUS, which is associated with a considerable rate of stroke recurrence 4-5 % per year. Despite recent scientific advances in acute ischemic stroke treatment in recent decades,consensus treatment of all guidelines is still ASA
Description: Number of stroke events during 1 year of study
Measure: Rate of stroke recurrence Time: Rate of stroke recurrence during one year fallow upDescription: Rate of major bleeding according to criteria of the International Society of Thrombosis and Hemostasis
Measure: Rate of major bleeding Time: During 1 year of studyDescription: Number of stroke or systemic embolisms recurrence during 1 year of study
Measure: Rate of stroke or systemic embolisms Time: During 1 year of studyDescription: Number of all cause mortality during study
Measure: Mortality rate Time: During 1year of studyDescription: Rate of non-major bleeding according to criteria of the International Society of Thrombosis and Hemostasis
Measure: Rate of non-major bleeding Time: During 1year of studyDescription: Rate of ICH during study
Measure: Rate of intracranial bleeding Time: During 1year of studyDescription: Rate of fatal bleeding in any site
Measure: Rate of fatal bleeding Time: During 1 year of studyAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports